Skip to main content

Table 2 Comparison of adherence assessment before and during the COVID-19 pandemic (n = 111)

From: Adherence to antihypertensive treatment during the COVID-19 pandemic: findings from a cross-sectional study

Adherence assessed

Adherence (%)

P-value

Yes

No

Before the pandemic period

99 (89.2)

12 (10.8)

0.000a

During the pandemic period

61 (54.9)

50 (45.1)

 
  1. aP-value obtained by McNemar test